about
The Hippo Pathway: Immunity and Cancer.YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting.YAP/TAZ Activation as a Target for Treating Metastatic Cancer.The Hippo pathway and cancer immunity: friend or foe?WWC3 inhibits epithelial-mesenchymal transition of lung cancer by activating Hippo-YAP signaling.The intracellular signalosome of PD-L1 in cancer cellsEpithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma
P2860
Q52621407-CD41B7FD-4B9D-4AA8-B24A-928F4B114C38Q53686708-43759745-9DD8-468F-BA67-6FF54B6884CBQ54977387-AFFC6184-DAD1-4F0C-9F89-DAE36ECEA4F7Q55005056-0C30C0BD-A082-4401-8CE5-415996FB126AQ55393865-F2361F6C-C9F5-4AD5-901B-61C9C6A271DAQ57067759-84CB09F5-2705-4FF8-8D8F-AC364730BB09Q57646291-A9A3054A-BE7A-4178-82C2-A26BC83CF816
P2860
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
YAP regulates PD-L1 expression in human NSCLC cells.
@en
YAP regulates PD-L1 expression in human NSCLC cells.
@nl
type
label
YAP regulates PD-L1 expression in human NSCLC cells.
@en
YAP regulates PD-L1 expression in human NSCLC cells.
@nl
prefLabel
YAP regulates PD-L1 expression in human NSCLC cells.
@en
YAP regulates PD-L1 expression in human NSCLC cells.
@nl
P2093
P2860
P356
P1433
P1476
YAP regulates PD-L1 expression in human NSCLC cells.
@en
P2093
David M Jablons
Geraldine Chan
Jinbai Miao
Ping-Chih Hsu
Yi-Lin Yang
Yucheng Wang
Yuyuan Dai
P2860
P304
114576-114587
P356
10.18632/ONCOTARGET.23051
P407
P577
2017-12-09T00:00:00Z